Israel - English - Ministry of Health

novartis israel ltd - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - methotrexate - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. palliation of acute lymphocytic leukemia. in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. methotrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. methotrexate is effective in the treatment of the advanced stages (iii and iv, peters’ staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

aloe 33mg, senna leaves 33mg, rhubarb roots 33mg, zedoary roots, manna, e.t.c

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - antazoline hydrochloride; tetrahydrozoline hydrochloride - solution, sterile - 0.50mg/ml - antazoline hydrochloride 0.50mg/ml; tetrahydrozoline hydrochloride 0.40mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - ciprofloxacin hcl eqv ciprofloxacin - solution, sterile - 3.0 mg/ml - ciprofloxacin hcl eqv ciprofloxacin 3.0 mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - proparacaine hcl - solution, sterile - 5.0 mg/ml - proparacaine hcl 5.0 mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - sodium chloride - solution, sterile - 50.00 mg/ml - sodium chloride 50.00 mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - timolol (as timolol maleate) - solution, sterile - 5 mg/ml - timolol (as timolol maleate) 5 mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - atropine sulfate - solution - 10.0 mg/ml - atropine sulfate 10.0 mg/ml

Singapore - English - HSA (Health Sciences Authority)

peter chia marketing pte ltd - chloramphenicol - solution, sterile - 5.0 mg/ml - chloramphenicol 5.0 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - methotrexate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - antineoplastic chemotherapy - methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. methotrexate may be used in combination with other chemotherapeutic agents for the palliative treatment of acute leukaemias, particularly acute lymphoblastic leukaemia. it may also be used in the treatment of burkitt's lymphoma, advanced stages (iii and iv, peters' staging system) of lymphosarcoma, especially in children, and in advanced cases of mycosis fungoides. high dose therapy - in high-dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic carcinoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy. psoriasis chemotherapy (see warning box) - methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.